Open plan designs: The good, the bad and the ugly; Fresenius adding 400-plus staffers
→ The open plan design has swept through biopharma like a prairie fire, dictating the layout for a whole range of new buildings and biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
